3 not yet recruiting, 3 recruiting, 1 completed. 2 Phase 2, 1 Early Phase 1, 1 Not applicable, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Not yet recruiting 1, Recruiting 1 |
| Early Phase 1 | 1 | Not yet recruiting 1 |
| Not applicable | 1 | Recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Age - Related Macular Degeneration (AMD): new trials by email Literature Review of Age - Related Macular Degeneration (AMD) trials Research Report on Age - Related Macular Degeneration (AMD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| An Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic Atrophy PST-611 - Geographic Atrophy, Age - Related Macular Degeneration (AMD) | Phase 2 | Not yet recruiting | Eyevensys | 24 | 2026-09-01 | 2026-07-16 |
| Effect of Fu's Subcutaneous Needling for Age-related Macular Degeneration FSN+Vitamin supplement, Vitamin Supplements - Age - Related Macular Degeneration (AMD) | Early Phase 1 | Not yet recruiting | Zhiming Yan | 38 | 2026-07-07 | 2025-08-13 |
| Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD Age - Related Macular Degeneration (AMD) | Recruiting | Maximilian Pfau | 150 | 2026-02-15 | 2026-04-07 | |
| Wide Field OCTA in Ocular Diseases Age - Related Macular Degeneration (AMD), Diabetic Macular Edema | Not yet recruiting | IRCCS San Raffaele | 200 | 2026-01-01 | 2025-12-30 | |
| Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD ONL1204 Opthalmic solution, Avacincaptad Pegol intravitreal solution, Sham - Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD) | Phase 2 | Recruiting | ONL Therapeutics | 324 | 2025-10-28 | 2026-09-10 |
| International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study Lens-Exchange, Add-on - Age - Related Macular Degeneration (AMD) | Not applicable | Recruiting | VisionCare, Inc. | 44 | 2025-09-23 | 2026-03-20 |
| Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection) Intravitreal Aflibercept Injection (IAI) - Age - Related Macular Degeneration (AMD) | Phase 4 | Completed | Regeneron Pharmaceuticals | 154 | 2012-11-01 | 2017-12-22 |
Macular Degeneration (7) · Geographic Atrophy (3) · Central Serous Chorioretinopathy (1) · Diabetic Retinopathy (1) · Myopia (1) · Retinal Diseases (1) · Retinal Vein Occlusion (1) · Retinitis Pigmentosa (1) · Stargardt Disease (1) · Uveitis (1) · Vitelliform Macular Dystrophy (1)
Eye Diseases (7) · Retinal Degeneration (7) · Retinal Diseases (6) · Cardiovascular Diseases (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Diabetes Complications (1) · Diabetes Mellitus (1) · Diabetic Angiopathies (1) · Embolism and Thrombosis (1) · Endocrine System Diseases (1) · Eye Diseases, Hereditary (1) · Genetic Diseases, Inborn (1) · Refractive Errors (1) · Retinal Dystrophies (1) · Thrombosis (1)
Geritol (1) · salicylhydroxamic acid (1)
Eyevensys (1) · IRCCS San Raffaele (1) · Maximilian Pfau (1) · ONL Therapeutics (1) · Regeneron Pharmaceuticals (1) · VisionCare, Inc. (1) · Zhiming Yan (1)
Germany (3) · France (2) · United States (2) · Austria (1) · Canada (1) · Czechia (1) · Greece (1) · Hungary (1) · Italy (1) · Poland (1) · Portugal (1) · Spain (1) · Switzerland (1) · United Kingdom (1)
Jian Sun (1) · Karine Bigot, PhD (1)
2025 (1)